2023(第三届) 3d细胞培养与类器官研讨会
目前,类器官培养被逐渐用于多项研究应用中,包括细胞生物学、再生机制、精准医疗以及药物毒性和药效试验等等,具有巨大的应用潜力。由生物谷作为主办之一的2023年第三届3d细胞培养与类器官研讨会将于2023年5月在上海举办,诚邀各位同行莅临参会!
2022(第二届) 3d细胞培养与类器官研讨会
因疫情影响,原定于7月29-30日的研讨会延期至9月29-30日!类器官应用在近两年来初露锋芒,作为一种体外模型,在疾病研究、肿瘤药敏、临床免疫、药物毒理、再生医学等多学科领域有重要的应用,具有广阔的发展前景及极大的应用潜力。为此生物谷诚邀各界专业人士齐聚一堂,共话类器官应用未来!
2021 3d细胞培养与类器官研讨会
生物谷、复旦大学遗传工程国家重点实验室类器官中心联合主办本次大会,诚邀政、产、学、研、医界人士共聚一堂,探讨目前类器官技术发展程度、存在问题及可能的解决方法,推动以类器官为基础的精准医疗研究及相应的临床转化,进一步加强类器官研究在肿瘤生物学、干细胞生物学、移植以及新药开发等领域的应用及融合。
The Wuxi International Bioforum 2019 and The 9th Cell death & disease Symposium - New drug discovery
Internationally renowned leading scientists and pioneers will present cutting-edge advances in cancer immunotherapy, targeted therapy with small molecules,and/or monoclonal antibodies, and novel cell therapeutic strategies. . New challenges, topical directions and novel approacheswill be discussed.
2019 (5th) International Conference on Gut Microecology and Health
At present, gut microbiome is a hot topic, which draws much attention. due to its curative effects on multiple diseases, gut microbiome is closely related to human health. Under the development of microbe imaging, metabolomics and single-cell sequencing technologies, new progress has been made in this field.
2018 International Forum on Innovative drug R&d
With a population of 1.3 billion people and a rapidly expanding economy, China has recently risen to become the third largest pharmaceutical market globally. Several multinational pharmaceutical companies have now located R&d centres in China, and Chinese pharmaceutical companies are increasingly focusing on innovative drug R&d.
2018 International Forum on Rare diseases and Orphan drugs
In some parts of the world, an orphan disease is a rare disease whose rarity means there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions to creating and selling such treatments. Orphan drugs are ones so created or sold.
2018 International Symposium on Neonatal Hereditary diseases and Translational Medicine
Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease presentations are often undifferentiated at birth. More than 3500 monogenic diseases have been characterized, but clinical testing is available for only some of them and many feature clinical and genetic heterogeneity.
2018 International Forum on Biotechnological drugs
Biotechnological drugs are a wide group of therapeutic agents obtained by means of genetic engineering methodologies. This forum will provide you with the latest technologies, the whole industry and the market of novel antibodies, antibody drugs, new vaccine development, new vaccine industry, protein modification in China.